A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome
Clinical trial NCT03458416 · TERMINATED
Trial details
- NCT number
- NCT03458416
- Sponsor
- Radius Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2019-07-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.